Dr Martens PLC
LSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
B
|
Bioscience Animal Health PCL
SET:BIS
|
TH |
|
I
|
Index Living Mall PCL
SET:ILM
|
TH |
|
D
|
Dhipaya Group Holdings PCL
SET:TIPH
|
TH |
|
Anglogold Ashanti PLC
F:HT3
|
UK |
|
C
|
Chic Republic PCL
SET:CHIC
|
TH |
|
Ampeak Energy Ltd
LSE:AMP
|
UK |
|
P
|
Pulsar Helium Inc
XTSX:PLSR
|
CA |
|
Dal'nevostochnoye Morskoye Parokhodstvo PAO
MOEX:FESH
|
RU |
|
K
|
K&K Superstore Southern PCL
SET:KK
|
TH |
|
Cipla Ltd
NSE:CIPLA
|
IN |
Wall Street
Price Targets
DOCS Price Targets Summary
Dr Martens PLC
According to Wall Street analysts, the average 1-year price target for
DOCS
is 102.15 GBX
with a low forecast of 76.76 GBX and a high forecast of 148.05 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DOCS's stock price target?
Price Target
102.15
GBX
According to Wall Street analysts, the average 1-year price target for
DOCS
is 102.15 GBX
with a low forecast of 76.76 GBX and a high forecast of 148.05 GBX.
What is Dr Martens PLC's Revenue forecast?
Projected CAGR
4%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's revenue is
10%.
The projected
CAGR
for the next 4 years is
4%.
What is Dr Martens PLC's Operating Income forecast?
Projected CAGR
15%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's operating income is
-1%.
The projected
CAGR
for the next 4 years is
15%.
What is Dr Martens PLC's Net Income forecast?
Projected CAGR
143%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's net income is
-20%.
The projected
CAGR
for the next 3 years is
143%.
